These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32955960)

  • 1. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
    Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
    J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline.
    Liu S; Luo X; Chong JSX; Jiaerken Y; Youn SH; Zhang M; Zhou JH;
    Hum Brain Mapp; 2024 Jul; 45(10):e26765. PubMed ID: 38958401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske GM; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Alzheimers Res Ther; 2024 Jul; 16(1):157. PubMed ID: 38987827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study.
    Kaskikallio A; Karrasch M; Koikkalainen J; Lötjönen J; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
    Dement Geriatr Cogn Disord; 2019; 48(5-6):297-307. PubMed ID: 32209796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study.
    Bernal J; Schreiber S; Menze I; Ostendorf A; Pfister M; Geisendörfer J; Nemali A; Maass A; Yakupov R; Peters O; Preis L; Schneider L; Herrera AL; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Rostamzadeh A; Glanz W; Buerger K; Janowitz D; Ewers M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Laske C; Munk MH; Spottke A; Roy N; Dobisch L; Dechent P; Scheffler K; Hetzer S; Wolfsgruber S; Kleineidam L; Schmid M; Berger M; Jessen F; Wirth M; Düzel E; Ziegler G
    Alzheimers Res Ther; 2023 May; 15(1):97. PubMed ID: 37226207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
    Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning.
    Bangen KJ; Thomas KR; Weigand AJ; Sanchez DL; Delano-Wood L; Edmonds EC; Carmichael OT; Schwarz CG; Brickman AM; Bondi MW;
    Neurobiol Aging; 2020 Feb; 86():134-142. PubMed ID: 31791658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
    Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
    Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
    [No Abstract]   [Full Text] [Related]  

  • 15. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH; Yun HJ; Sunwoo MK; Hong JY; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White Matter Hyperintensity Associations with Cerebral Blood Flow in Elderly Subjects Stratified by Cerebrovascular Risk.
    Bahrani AA; Powell DK; Yu G; Johnson ES; Jicha GA; Smith CD
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):779-786. PubMed ID: 28063772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative MRI of cerebral white matter hyperintensities: A new approach towards understanding the underlying pathology.
    Iordanishvili E; Schall M; Loução R; Zimmermann M; Kotetishvili K; Shah NJ; Oros-Peusquens AM
    Neuroimage; 2019 Nov; 202():116077. PubMed ID: 31398433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment.
    Hirao K; Yamashita F; Sakurai S; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    Geriatr Gerontol Int; 2021 Aug; 21(8):644-650. PubMed ID: 34105230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment.
    Calcetas AT; Thomas KR; Edmonds EC; Holmqvist SL; Edwards L; Bordyug M; Delano-Wood L; Brickman AM; Bondi MW; Bangen KJ; For The Alzheimer's Disease Neuroimaging Initiative
    Neurobiol Aging; 2022 Oct; 118():1-8. PubMed ID: 35809348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
    Bachmann D; von Rickenbach B; Buchmann A; Hüllner M; Zuber I; Studer S; Saake A; Rauen K; Gruber E; Nitsch RM; Hock C; Treyer V; Gietl A
    Alzheimers Res Ther; 2024 Apr; 16(1):67. PubMed ID: 38561806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.